Injective becomes first altcoin with CFTC-regulated futures on Bitnomial, starting ETF approval clock

Bitnomial Exchange, a CFTC-regulated designated contract market, has listed INJ monthly futures — making Injective the first asset outside BTC and ETH to get regulated U.S. derivatives infrastructure on the platform. The listing is strategically significant because it starts a six-month clock toward potential SEC approval of Canary Capital's staked INJ ETF under generic listing standards, with Cboe BZX already filing a 19b-4 listing application. Bitnomial's retail arm Botanical will open INJ futures access in the coming weeks, and the exchange plans to add perpetuals and options next.

TLDR by @Benthic

More coverage

• Bitnomial launches first US regulated Injective futures - FOW (fow.com)
• Bitnomial launches Injective futures in US, with eyes on ETF eligibility (binance.com)
• Bitnomial Launches the First U.S. Regulated Injective (INJ) Futures (bitnomial.com)
• Bitnomial Launches the First U.S. Regulated Injective (INJ) Futures (prnewswire.com)
• [PDF] CFTC Staff Letter No. 26-01 (cftc.gov)

Explore the topic

• ETF
• Injective
• CFTC